jibi to rinsho
Online ISSN : 2185-1034
Print ISSN : 0447-7227
ISSN-L : 0447-7227
Volume 43, Issue 3
Displaying 1-12 of 12 articles from this issue
  • ZHONG Ren
    1997 Volume 43 Issue 3 Pages 297-300
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    In clinical studies the vulnerability of the orbicularis oculi muscle was greater than that for the oris muscle and the recovery of the orbicularis oculi muscle was also slower than that observed for the oris muscle. Using guinea pigs, a transient palsy of the facial nerve was made. Evoked electromyograms of the muscles were thus comparatively analyzed. The threshold difference between the pre-compression and post-compression response of the orbicularis oculi muscle was greater than for the oris muscle. The recovery of the orbicularis oculi muscle was also slower than that for the oris muscle. These results showed that the nerve fibers innervationg the orbicularis oculi muscle had a greater vulnerability than that of the nerve fibers innervating the orbicularis oris muscle. In addition, the strong resistance to the compression of the nerve fibers innervating the orbicularis oris muscle was also observed.
    Download PDF (7758K)
  • Tetsuo ITOKAZU, Shizuo KOJYA, Norihide MAESHIRO, Tatsuhito OOWA, Yoshi ...
    1997 Volume 43 Issue 3 Pages 301-304
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    Twenty-eight patients with either T1NO or T2N0 tongue cancer who were treated by laser surgery at the Department of Otorhinolaryngology at the University of the Ryukyus, Faculty of Medicine from 1984 through 1993a re herein reviewed. Cervical recurrences without primary recurrence were found in 9 cases. In 7 of those cases, recurring cervical lesions were controlled by a neck dissection. Four of the 9 cases with subsequent cervical metastasis showed muscular invasion, while 2 cases showed vascular invasion. Therefore, muscular invasion and vascular invasion are thus considered to be important factors for predicting the development of post-operative cervical metastasis.
    Download PDF (7143K)
  • Takeshi AKISADA, Yozo ORITA, Yukihiro SATO, Toru HANDA, Tsuyoshi YOSHI ...
    1997 Volume 43 Issue 3 Pages 305-309
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    Most patients with Ramsay Hunt syndrome demonstrate facial nerve palsy, herpes zoster oticus and an 8th nerve dysfunction in those with the complete syndrome. Recently we experienced a case of herpes zoster oticus without facial nerve palsy (Haymann type IV). A 13-year-old female complained of vertigo with the onset of left herpes zoster oticus. She had no hearing impairment and her pure tone audiogram was normal. Positional and head shaking nystagmus (HSN) to the right and canal paresis on the left were also detected. The vertigo and temporalgia both responded well to the treatment, however, the horizontal and circular HSN to the right continued for eight months. This is a case of herpes zoster oticus demonstrating only a vestibular dysfunction and such cases are considered to be very rare.
    Download PDF (10643K)
  • Ikuo NAGAYAMA, Keiko KITA, Hajime TAKESHITA, Hideaki SHIGA, Mitsuru FU ...
    1997 Volume 43 Issue 3 Pages 310-313
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    Tumors of the sublingual gland are uncommon but known to be malignant once they occur. We herein report a 53-year-old male patient who presented with a tumor in the sublingual region which was diagnosed to be adenoid cystic carcinoma. His chief complaint was tongue pain, accompanied with some discomfort of the tongue, a lump sensation and dysarthria The right half of the tongue showed atrophy of the tongue muscle and fasciculation. A tumor was detected in the sublingual region of the right half of the tongue measuring 3 cm in diameter and demonstrating tenderness on palpation. MRI showed T2 enhanced opacity and a Ga scan hot nodule. A specimen obtained just before the operation was diagnosed as adenoid cystic carcinoma. The tumor was resected via the transmandibular approach, combined with a supraomohyoid neck dissection, while the defect of the floor of the mouth was then reconstructed with a peroneal flap. Postoperative radiation was performed because of the stump invasion of the nerve. The post-operative evaluation of mastication and articulation was good. The patient was discharged from the hospital with no sign of recurrence after receiving the combined treatment regimen of surgery and radiation over a three-month period.
    Download PDF (9812K)
  • Tetsuya NODA
    1997 Volume 43 Issue 3 Pages 314-317
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    The relationship between gag reflex and motion sickness was studied based on questionnaires to 211 subjects who presented complaining of either discomfort or pain in the pharynx and oral cavity but who were all almost normal in physical examination. The patients were classified according to the reaction of the gag reflex based on the indirect laryngoscopy findings into the following three groups: group 1, in which the subjects had a gag reflex without the pharynx being touched with a mirror of a laryngoscope; group 2, in which they demonstrated a reflex after being touched by the mirror, and group 3, which demonstrated a silightly different reflex. The incidence of motion sickness was 44%, 41%a nd 10% in males, 87%, 63% and 41% in females in groups 1, 2 and 3, respectively. These findings thus suggested that persons with a sensitive gag reflex might therefore demonstrate an increased susceptibility to motion sickness.
    Download PDF (6524K)
  • Hiroyuki YAMASHITA, Tooru YANAI, Masamichi NISHIO, Jiro TAYAMA, Natsuh ...
    1997 Volume 43 Issue 3 Pages 318-325
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    Pharyngolaryngography is a useful method for both examining the swallowing function and diagnosing laryngeal lesions, and requires the use of a contrast medium that is safe even when aspirated into the bronchi. As a contrast medium, Dionosil had been successfully used in the past, however, both its prodiction and marketing have been discontinued, and therefore a substitute is required. In this study we focused our attention to Iotrolan 300 as a contrast medium for pharyngolaryngography. The characteristics of this medium are its isotonicity to the body fluid, its low chemotoxicity and low degree of local irritation. Both the safety and usefulness of this medium were examined in 61 patients who demonstrated a tendency toward aspiration. Images on the swallowing motion and aspiration were observed with good contrast, and information useful for planning rehabilitation exercises on swallowing or deciding on a surgical operation as well as choosing the most optimal operation method was obtained. In all of the 43 tested subjects, no side effects such as pneumonia or fever were observed. Based on the above findings, Iotrolan 300 is thus considered to be a safe and useful contrast medium for pharyngolaryngography.
    Download PDF (14484K)
  • Satoshi OGINO, Shin-ichiro WATANABE, Morihiro IRIFUNE, Tamotsu HARADA
    1997 Volume 43 Issue 3 Pages 326-333
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    The positive rates of several specific IgE antibodies were examined using the CAP-RAST system in the sera from 184 patients with nasal allergies consisting of 97 males and 87 females. The highest postive rate was 58% for house dust (HD) and D. farinae (DF), followed by 46% for Japanese cedar, 38% for Japanese cypress and 31% for orchard grass. The positive rate for candida was the lowest within the 10 identified allergens. Overall, the positive rates for males tended to exceed those of females for each allergen. In general, HD and DF showed a higher positive rate in younger patients, on the other hand, the peak age for the positive rates for pollen was between the ages of 21 and 40 years old. About 70% of the patients with Japanese cedar allergy also reacted to Japanese cypress allergen. A good correlation was thus found between the CAP-RAST units of Japanese cedar allergen and those of Japanese cypress allergen.
    Download PDF (11103K)
  • An analysis based on the check-up data from Shiraoi-cho, Japan
    Akira MIYOSHI, Ni FENG, Takeyuki SAMBE, Emiko SUZUKI, Kei TOKUMARU, Le ...
    1997 Volume 43 Issue 3 Pages 334-339
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    The prevalence rate of nasal allergy in Japan increased drastically in the ten-year period from 1970 to 1980, and the rate was not generally thought to increase thereafter. However, a systematic comparison of our physical examination results for 6 years in the same subjects under the same conditions in Shiraoi-cho, showed that the rate has continued to increase even after 1989. The drastic increase in the 1979's resulted from the apparent proliferation of increase factors. It is highly possible that the lack of any increase in the 1980's resulted from a disappearance of these apparent increase factors, even though the increasing tendency actually persisted. As a result, the occurrence of nasal allergy in Japan therefore still seems to be increasing.
    Download PDF (9123K)
  • Shunkichi BABA, Naoya MIYAMOTO, Ginichiro ICHIKAWA, Takuya YAMAKAWA, M ...
    1997 Volume 43 Issue 3 Pages 340-352
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    After orally administering 200mg of prulifloxacin, the concentrations of UFX (an active metabolite of PUFX) in the paranasal sinus tissue ranged from 1.13 to 1.47μg/g at 70 to 120 minutes. The penetration ratios were 0.51 to 1.85 in the maxillary sinus mucosa, 1.46 to 2.63 in the ethmoidal sinus mucosa and 0.80 to 1.00 in the nasal polyp. The clinical efficacy rate at a daily dose of 200 to 600mg of PUFX was 84% (94% for acute sinusitis and 71% for an acute exacerbation of chronic sinusitis), while the radiological efficiency rate was 57%. The bacteriological eradication rates were 95% for gram-positive monomicrobial cases, 89%, for gram-negative cases and 100% for anaerobic monomicrobial cases. The rate for polymicrobial cases was 86%. Adverse reactions were observed in 2 cases (one case each of rash and diarrhea), and these symptoms disappeared during treatment (one case received a decreased dose). No abnormal changes were observed in the laboratory findings in any of the cases.
    Download PDF (20737K)
  • Shunkichi BABA, Naoya MIYAMOTO, Ginichiro ICHIKAWA, Takuya YAMAKAWA, M ...
    1997 Volume 43 Issue 3 Pages 353-365
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    After orally administering 200mg of prulifloxacin, the concentrations of UFX (an active metabolite of PUFX) were found to range from 1.10 to 1.79μg/g in the palatine tonsillar tissue at 60 to 300 minutes and 1.23 to 4.13μg/g in the salivary gland tissue at 70 to 120 minutes, while the penetration ratios were 0.50 to 4.37 in the palatine tonsillar tissue. The clinical efficacy rates were 85% for tonsillitis, 75% for pharyngolaryngitis, 67% for suppurative sialadenitis at doses ranging from 200 to 600mg daily of PUFX. Regarding bacteriological efficacy, the eradication rates were 90% for tonsillitis and 80% for other diseases. As for the bacteriological response, the eradication rate was 92% in cases of tonsillitis. Adverse reactions were observed in 3 cases including 1 case each of eruption, nausea and loose stools, and all such reactions disappeared either during or after treatment. Abnormal changes in the laboratory findings were observed in 3 cases including an increase of eosinophiles in 2, and an elevation of total bilirubin in 1.
    Download PDF (21453K)
  • Shunkichi BABA, Naoya MIYAMOTO, Ginichiro ICHIKAWA, Takuya YAMAKAWA, M ...
    1997 Volume 43 Issue 3 Pages 366-378
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    The concentration of UFX (an active metabolite of PUFX) in middle ear tissue ranged from 5.24 to 8.00μg/g at 2 to 3 hours after orally administering 200mg of PUFX and thereafter remained at a level of 8.25μg/g until 9 hours later. The clinical efficacy rates were 100% for acute otitis media, 63% for an acute exacerbation of chronic Otitis media and 75% for otitis externa in daily PUFX doses ranging from 200 to 600 mg. Regarding bacteriological efficacy, the eradication rates were 72% for otitis media and 83% for otitis externa. In the bacteriological response in cases of otitis media, the eradication rates were 74% for gram-positive bacteria and 86% for gram-negative bacteria-Adverse reactions were observed in 2 cases (including one case each of dizziness and diarrhea-nausea), but these symptoms disappeared after withdrawal. Abnormal changes in the laboratory findings were also observed in 3 cases (including one case each of increased eosinophiles, an elevated S-GOT·S-GPT level, and an elevated serum potassium level).
    Download PDF (21048K)
  • 1997 Volume 43 Issue 3 Pages 381-385
    Published: May 20, 1997
    Released on J-STAGE: May 10, 2013
    JOURNAL FREE ACCESS
    Download PDF (8289K)
feedback
Top